Background As countries move towards the UNAIDS's 95-95-95 targets and with strong
evidence that undetectable equals untransmittable, it is increasingly important to assess …

Background The 90-90-90 goal to achieve viral suppression in 90% of all human
immunodeficiency virus (HIV)–infected people on antiretroviral treatment (ART) is especially …

Background: Having 90% of patients on antiretroviral therapy (ART) and achieving an
undetectable viral load (VL) is 1 of the 90: 90: 90 by 2020 targets. In this global analysis, we …

OBJECTIVE: To establish estimates of viral suppression in low-and middle-income countries
(LMICs) in patients who received antiretroviral therapy (ART) for human immunodeficiency …

Background After the launching of the «Test & Treat» strategy and the wider accessibility to
viral load (VL), evaluating virological success (VS) would help in meeting the UNAIDS …

Background The length of time that people with HIV on antiretroviral therapy (ART) with viral
load suppression will be able to continue before developing viral rebound is unknown. We …

Background While the proportion of HIV-positive children (under 15 years) enrolled on
antiretroviral therapy (ART) has increased in recent years, up to 60% of children started on …

Objective The aim of the study was to evaluate time to virological suppression in a cohort of
individuals who started highly active antiretroviral therapy (HAART), and to explore the …

Abstract Background. More than 11.7 million people are currently receiving antiretroviral
therapy (ART) in low-and middle-income countries (LMICs), and focused efforts are needed …

Background Achieving undetectable viral load is crucial for the reduction of HIV
transmissions, AIDS-related illnesses and death. Adolescents (10 to19 years) living with HIV …